Emerging Growth Equities upgrades CryoLife (NYSE: CRY) from Hold to Buy; Weakness expected to be temporary and valuation is attractive.
This article: 231 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE